T-type Ca\(^ {++} \) channel α1G inhibitors are a class of compounds that specifically target and inhibit the activity of the α1G subunit of T-type calcium channels. T-type calcium channels are voltage-gated channels that regulate the influx of calcium ions (Ca\(^ {++} \)) into cells, playing a critical role in cellular excitability, signal transduction, and a variety of physiological processes. The α1G subunit, also known as Cav3.1, is one of the pore-forming subunits of the T-type calcium channels, and it is responsible for the low-threshold activation of these channels, allowing calcium ions to flow into cells when the membrane potential is slightly depolarized. This subunit is primarily expressed in the nervous system, heart, and certain endocrine tissues, where it contributes to processes such as rhythmic oscillations, pacemaker activity, and intracellular calcium signaling. Inhibitors of the α1G subunit work by binding to specific sites on the channel and preventing its activation, thereby reducing or blocking the influx of calcium ions.
The chemical structure of T-type Ca\(^ {++} \) channel α1G inhibitors can vary, and they function through different mechanisms of action. Some inhibitors bind directly to the channel's pore or voltage-sensing regions, preventing it from opening in response to changes in membrane potential. Others may act allosterically, binding to alternative sites on the α1G subunit and inducing conformational changes that reduce the channel's ability to conduct calcium ions. By inhibiting these channels, the compounds effectively disrupt the flow of calcium into the cell, which influences the cell's excitability and intracellular signaling pathways that rely on calcium as a second messenger. Studying T-type Ca\(^ {++} \) channel α1G inhibitors helps researchers understand the specific role that this subunit plays in calcium dynamics and how it contributes to the broader regulatory mechanisms in excitable cells, such as neurons and muscle cells. Additionally, these inhibitors provide insight into how T-type calcium channels function in processes like neuronal firing, cardiac rhythm, and hormone release.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
A calcium channel blocker that primarily affects L-type channels but can also alter T-type channel function by modulating cellular calcium influx. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Another calcium channel blocker, affecting multiple calcium channel subtypes, potentially influencing T-type channel activity indirectly. | ||||||
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Although primarily a diuretic, it can modulate ion transport and indirectly influence calcium channel activities. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
A benzothiazepine class of calcium channel blockers, primarily affecting L-type but possibly modulating T-type channels indirectly. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
As a trace element, it can modulate various ion channels and receptors, potentially affecting T-type calcium channel function. | ||||||
Isradipine | 75695-93-1 | sc-201467 sc-201467A | 10 mg 50 mg | $88.00 $324.00 | 1 | |
A calcium channel blocker with potential indirect effects on T-type calcium channels through vascular and neuronal modulation. | ||||||
Mibefradil dihydrochloride | 116666-63-8 | sc-204083 sc-204083A | 10 mg 50 mg | $213.00 $865.00 | 4 | |
it's known to affect both T-type and L-type calcium channels | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
Primarily an L-type calcium channel blocker, it may have secondary effects on T-type channels through systemic calcium modulation. | ||||||